147 related articles for article (PubMed ID: 15956274)
1. Serum anticholinergic activity and cognition in patients with moderate-to-severe dementia.
Chew ML; Mulsant BH; Pollock BG
Am J Geriatr Psychiatry; 2005 Jun; 13(6):535-8. PubMed ID: 15956274
[TBL] [Abstract][Full Text] [Related]
2. Serum anticholinergic activity in a community-based sample of older adults: relationship with cognitive performance.
Mulsant BH; Pollock BG; Kirshner M; Shen C; Dodge H; Ganguli M
Arch Gen Psychiatry; 2003 Feb; 60(2):198-203. PubMed ID: 12578438
[TBL] [Abstract][Full Text] [Related]
3. Increased cortisol levels and anticholinergic activity in cognitively unimpaired patients.
Plaschke K; Kopitz J; Mattern J; Martin E; Teschendorf P
J Neuropsychiatry Clin Neurosci; 2010; 22(4):433-41. PubMed ID: 21037129
[TBL] [Abstract][Full Text] [Related]
4. The cognitive cost of anticholinergic burden: decreased response to cognitive training in schizophrenia.
Vinogradov S; Fisher M; Warm H; Holland C; Kirshner MA; Pollock BG
Am J Psychiatry; 2009 Sep; 166(9):1055-62. PubMed ID: 19570929
[TBL] [Abstract][Full Text] [Related]
5. Measures of anticholinergic drug exposure, serum anticholinergic activity, and all-cause postdischarge mortality in older hospitalized patients with hip fractures.
Mangoni AA; van Munster BC; Woodman RJ; de Rooij SE
Am J Geriatr Psychiatry; 2013 Aug; 21(8):785-93. PubMed ID: 23567395
[TBL] [Abstract][Full Text] [Related]
6. Anticholinergic drugs and functional, cognitive impairment and behavioral disturbances in patients from a memory clinic with subjective cognitive decline or neurocognitive disorders.
Dauphinot V; Mouchoux C; Veillard S; Delphin-Combe F; Krolak-Salmon P
Alzheimers Res Ther; 2017 Aug; 9(1):58. PubMed ID: 28764796
[TBL] [Abstract][Full Text] [Related]
7. Serum anticholinergic activity and cerebral cholinergic dysfunction: an EEG study in frail elderly with and without delirium.
Thomas C; Hestermann U; Kopitz J; Plaschke K; Oster P; Driessen M; Mundt C; Weisbrod M
BMC Neurosci; 2008 Sep; 9():86. PubMed ID: 18793418
[TBL] [Abstract][Full Text] [Related]
8. Serum anticholinergic activity and postoperative cognitive dysfunction in elderly patients.
Rossi A; Burkhart C; Dell-Kuster S; Pollock BG; Strebel SP; Monsch AU; Kern C; Steiner LA
Anesth Analg; 2014 Oct; 119(4):947-955. PubMed ID: 25089730
[TBL] [Abstract][Full Text] [Related]
9. The impact of anticholinergic burden in Alzheimer's dementia-the LASER-AD study.
Fox C; Livingston G; Maidment ID; Coulton S; Smithard DG; Boustani M; Katona C
Age Ageing; 2011 Nov; 40(6):730-5. PubMed ID: 21926432
[TBL] [Abstract][Full Text] [Related]
10. Adverse effects of anticholinergic activity on cognitive functions in Alzheimer's disease.
Konishi K; Hori K; Uchida H; Watanabe K; Tominaga I; Kimura M; Hosoyamada M; Shibasaki T; Kataoka A; Hachisu M
Psychogeriatrics; 2010 Mar; 10(1):34-8. PubMed ID: 20594285
[TBL] [Abstract][Full Text] [Related]
11. Anticholinergic drug use, serum anticholinergic activity, and adverse drug events among older people: a population-based study.
Lampela P; Lavikainen P; Garcia-Horsman JA; Bell JS; Huupponen R; Hartikainen S
Drugs Aging; 2013 May; 30(5):321-30. PubMed ID: 23475596
[TBL] [Abstract][Full Text] [Related]
12. Assessment of Cognitive Dysfunction Caused by Anticholinergic Burden in Japanese Alzheimer's Disease Patients, Using the Most Commonly Used Scales in Japan.
Konishi K; Hori K; Hachisu M; Tomioka H; Tani M; Hosoi M; Kitajima Y; Inamoto A; Iwanami A
Nihon Shinkei Seishin Yakurigaku Zasshi; 2015 Nov; 35(5-6):113-8. PubMed ID: 26785521
[TBL] [Abstract][Full Text] [Related]
13. Association of anticholinergic load with impairment of complex attention and memory in schizophrenia.
Minzenberg MJ; Poole JH; Benton C; Vinogradov S
Am J Psychiatry; 2004 Jan; 161(1):116-24. PubMed ID: 14702259
[TBL] [Abstract][Full Text] [Related]
14. Neuropsychological profile of patients with Parkinson's disease without dementia.
Janvin C; Aarsland D; Larsen JP; Hugdahl K
Dement Geriatr Cogn Disord; 2003; 15(3):126-31. PubMed ID: 12584427
[TBL] [Abstract][Full Text] [Related]
15. Small longitudinal study of serum anticholinergic activity and cognitive change in community-dwelling older adults.
Kashyap M; Mulsant BH; Tannenbaum C
Am J Geriatr Psychiatry; 2015 Mar; 23(3):326-9. PubMed ID: 25450763
[TBL] [Abstract][Full Text] [Related]
16. Higher anticholinergic drug scale (ADS) scores are associated with peripheral but not cognitive markers of cholinergic blockade. Cross sectional data from 21 Norwegian nursing homes.
Kersten H; Molden E; Willumsen T; Engedal K; Bruun Wyller T
Br J Clin Pharmacol; 2013 Mar; 75(3):842-9. PubMed ID: 22924454
[TBL] [Abstract][Full Text] [Related]
17. Prefrontal gray matter morphology mediates the association between serum anticholinergicity and cognitive functioning in early course schizophrenia.
Wojtalik JA; Eack SM; Pollock BG; Keshavan MS
Psychiatry Res; 2012 Nov; 204(2-3):61-7. PubMed ID: 23158779
[TBL] [Abstract][Full Text] [Related]
18. Association between anticholinergic drugs and apolipoprotein E epsilon4 allele and poorer cognitive function in older cardiovascular patients: a cross-sectional study.
Uusvaara J; Pitkala KH; Tienari PJ; Kautiainen H; Tilvis RS; Strandberg TE
J Am Geriatr Soc; 2009 Mar; 57(3):427-31. PubMed ID: 19278396
[TBL] [Abstract][Full Text] [Related]
19. Effects of anticholinergic drugs on cognitive function in older Australians: results from the AIBL study.
Sittironnarit G; Ames D; Bush AI; Faux N; Flicker L; Foster J; Hilmer S; Lautenschlager NT; Maruff P; Masters CL; Martins RN; Rowe C; Szoeke C; Ellis KA;
Dement Geriatr Cogn Disord; 2011; 31(3):173-8. PubMed ID: 21389718
[TBL] [Abstract][Full Text] [Related]
20. The influence of preoperative serum anticholinergic activity and other risk factors for the development of postoperative cognitive dysfunction after cardiac surgery.
Plaschke K; Hauth S; Jansen C; Bruckner T; Schramm C; Karck M; Kopitz J
J Thorac Cardiovasc Surg; 2013 Mar; 145(3):805-11. PubMed ID: 22935445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
